Literature DB >> 4168522

Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.

G R Fearnley, R Chakrabarti, E D Hocking.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4168522     DOI: 10.1016/s0140-6736(67)90286-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  Antifibrin action of phenformin.

Authors:  R N Banerjee; V Kumar; S R Rao; A L Sahni; M Arya; J Bardhan
Journal:  Diabetologia       Date:  1975-04       Impact factor: 10.122

Review 2.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

3.  Phenformin and stanozolol in blood fibrinolytic activity.

Authors:  I S Menon; W J Cunliffe; D Weightman; H A Dewar
Journal:  Br Med J       Date:  1970-02-14

4.  Pharmacological fibrinolysis in diabetes mellitus.

Authors:  R Chakrabarti; G R Fearnley
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

5.  The use of intra-arterial Urokinase in a case of recurrent arterial occlusion.

Authors:  B J Boucher; E M Connolly; S C Farrow
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

6.  Clinical experience with brinase.

Authors:  E P Frisch
Journal:  J Clin Pathol       Date:  1972-07       Impact factor: 3.411

7.  The fibrinolytic system.

Authors:  G R Fearnley
Journal:  Proc R Soc Med       Date:  1971-09

8.  Effect of ethyloestrenol on fibrinolysis in the vessel wall.

Authors:  U Hedner; I M Nilsson; S Isacson
Journal:  Br Med J       Date:  1976-09-25

Review 9.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects.

Authors:  G D Lowe; J E Thomson; M M Reavey; C D Forbes; C R Prentice
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.